— Know what they know.
Not Investment Advice

OLMA NASDAQ

Olema Pharmaceuticals, Inc.
1W: +1.7% 1M: -13.4% 3M: -41.6% YTD: -44.4% 1Y: +176.8% 3Y: +121.8% 5Y: -44.0%
$13.68
-0.38 (-2.70%)
 
Weekly Expected Move ±5.8%
$12 $13 $14 $14 $15
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 29 · $1.2B mcap · 75M float · 1.98% daily turnover · Short 53% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-185M
Net Income
-43.6% YoY
$-149M
Free Cash Flow
-19.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-41.7%
ROA-37.6%
ROIC620.7%

Valuation

P/E-7.6
P/B2.9
EV/EBITDA-5.2

Leverage

Debt/Equity0.00
Current Ratio9.95
Interest Cov.0.0x

Quality Scores

Piotroski F2/9
Altman Z15.01
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms